CD4 and myeloid sarcoma: For example, anti-CD4 antibodies have been tested in diseases like rheumatoid arthritis (RA) and multiple sclerosis (MS) to deplete activated CD4+ T cells, although challenges such as generalized immune suppression remain [35].